For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220729:nRSc3278Ua&default-theme=true
RNS Number : 3278U Impact Healthcare REIT PLC 29 July 2022
29 July 2022
Impact Healthcare REIT plc
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
TOTAL VOTING RIGHTS
In conformity with DTR 5.6.1R, the Company announces that, as at 29 July 2022,
the Company's issued share capital consisted of 404,764,328 Ordinary Shares.
There are no ordinary shares held in Treasury.
The total number of voting rights of the Company is 404,764,328 and this
figure may be used by Shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to, their interest in the Company under the FCA's Disclosure Guidance
and Transparency Rules.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP via Maitland/amo
Andrew Cowley
Mahesh Patel
David Yaldron
Jefferies International Limited +44 (0) 20 7029 8000
Tom Yeadon
Andrew Morris
Ollie Nott
Winterflood Securities +44 (0) 20 3100 0000
Darren Willis
Neil Langford
Maitland/amo (Communications Adviser) 07747 113 930
James Benjamin impacthealth-maitland@maitland.co.uk
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at
www.impactreit.uk (http://www.impactreit.uk/) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRBUGDRLSDDGDC